Results 51 to 60 of about 57,585 (206)

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

Neurourology and Urodynamics, EarlyView.
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang, William I. Jaffe, Ariana L. Smith   +2 more
wiley   +1 more source

Extended spectrum beta lactamase producing E.coli isolated from Gorgan, North of Iran

Medical Laboratory Journal, 2012
Background and objectives: The increase of ESBL producing E.coli can create a tremendous difficult y for the health system. These isolates leads to rapid transmission of causative genes to other clinically important bacteria and synchronously increased ...
Babaii Kochaksaraii M, NasrolahiOmran A, Javid N, Shakeri F, Yazdi M, Ghaemi E A   +5 more
doaj  

Factors Underlying Choice and Change of Absorbent Incontinence Products in Women With Urinary Incontinence

Neurourology and Urodynamics, EarlyView.
ABSTRACT Background and Objective Urinary incontinence (UI) is common in women. For up to 77%, the use of absorbent continence products (pads) is central to management. Pad changes are common and reasons for change are not fully described. We hypothesized that women change their pads for many reasons other than wetness and at saturation levels well ...
Sarah Qureshi, Saima Rajabali, Adrian Wagg   +2 more
wiley   +1 more source

Evaluation of the Diagnostic Performance of the LINEAR Cromatest and Laboquick URS 10-T Dipsticks Among Urinary Tract Infection Suspects in Addis Ababa, Ethiopia: A Cross-Sectional Study

Research and Reports in Urology, 2023
Yosef Gebretensaie,1,* Abay Atnafu,2,* Yonas Alemu,3 Selfu Girma,2 Kassu Desta4,* 1American Advanced Medical Laboratory, American Medical Center, Addis Ababa, Ethiopia; 2Armauer Hansen Research Institute, Addis Ababa, Ethiopia; 3Department of
Gebretensaie Y, Atnafu A, Alemu Y, Girma S, Desta K   +4 more
doaj  

Urodynamic and Anamnestic Predictors for Individual Dose Adjustment of Intravesical Oxybutynin in Neurogenic Detrusor Overactivity: Results From the UPSIDE Study

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Intravesical oxybutynin (IVO) is a 2nd line treatment option for patients with neurogenic detrusor overactivity (NDO) who are not adequately managed by oral anticholinergics. The UPSIDE study aimed to identify urodynamic and anamnestic predictors for achieving a therapeutically satisfactory dose (TSD) of 1 mg/mL IVO and to ...
Arndt Van Ophoven, Severine Banek, Kristin Becker, Markus Heibel, Almut Hirsch, Margot Kieruj, Ines Kurze, Anja Lingnau, Barbara Ludwikowski, Tobias Luithle, Fabian Queissert, Wolfgang Rösch, Oliver Schindler, Regina Stredele, Thomas Michael Karl Völkl, Quentin Leidl, Michael Gedamke   +16 more
wiley   +1 more source

Prevalence of Bacterial Urinary Tract Infection and Antimicrobial Susceptibility Patterns Among Diabetes Mellitus Patients Attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Infection and Drug Resistance, 2021
Gebremdhin Yenehun Worku,1 Yerega Belete Alamneh,2 Woldaregay Erku Abegaz3 1Department of Microbiology, Addis Ababa Public Health Research and Emergency Management Directorate, Addis Ababa, Ethiopia; 2Department of Microbiology, Immunology and ...
Yenehun Worku G, Belete Alamneh Y, Erku Abegaz W   +2 more
doaj  

Beyond Joint Hypermobility: Investigating Bladder Dysfunction in Hypermobile Ehlers‐Danlos Syndrome

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction and Objectives Hypermobile Ehlers‐Danlos Syndrome (hEDS) is the most common subtype of Ehlers‐Danlos Syndrome, a group of connective tissue disorders caused by collagen abnormalities. While musculoskeletal features of hEDS are well characterized, its impact on visceral organs, including the bladder, remains underexplored.
Marium Ansari, Mallory Pine, Viktoriya Sapkalova, Emily Chan Brodowsky, Charles R. Powell, Ramzy T. Burns   +5 more
wiley   +1 more source

Sacral Neuromodulation in the Management of Refractory Pediatric Lower Urinary Tract Dysfunction

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Sacral neuromodulation is currently used in the pediatric patient population for refractory lower urinary tract dysfunction (LUTD). Evidence, however, is currently limited for institutional experiences of long‐term outcomes for sacral neuromodulation in the pediatric patient population.
Megan A. Stout, Lauren E. Corona, Li‐Ching Huang, Tatsuki Koyama, Lindsay A. Gil, Shelly King, Benjamin M. Whittam, Seth A. Alpert, John C. Pope   +8 more
wiley   +1 more source

Studies on Feline lower Urinary Tract Disease in Egypt Cat Population [PDF]

Journal of Applied Veterinary Sciences
The present study was conducted on 56 cats (49 males and 7 females) who presented with signs of feline lower urinary tract disease (FLUTD). Abdominal radiographs and ultrasounds, urinalysis, bacterial culture, and stone analysis were performed.
Shimaa Ayoub, Mohamed Mostafa, Ahmed Abdelgalil   +2 more
doaj   +1 more source

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Sacral nerve stimulation (SNS) is an established therapy for refractory urinary incontinence, yet the 2025 Wasteful and Inappropriate Service Reduction Model (WISeR) designated it as requiring mandatory prior authorization. No analysis has examined how U.S.
Thriaksh Rajan, Andre Revnew, David Sheyn, Adonis Hijaz, Ramy Abou Ghayda   +4 more
wiley   +1 more source